Learning Session II


May 22, 2012

  • Agenda (doc)
  • Welcome and Overview - Dennis McCarty, PhD
  • Pharmacotherapies for Alcohol Use Disorders - Marc Fishman, MD
  • Clinical Perspectives: Buprenorphine- Robert Schwartz, MD
  • Staff Resistance - Kim Johnson, MBA
  • Business Case vs Cost Effectiveness - Jay Ford, PhD